Quantix

Quantix Bio is a synthetic biology company specializing in the development of programmable gene therapies through the design of synthetic promoters. The company's platform utilizes machine learning and high-throughput screening to engineer DNA sequences that precisely control the timing, location, and intensity of gene expression. By overcoming the limitations of natural promoters, such as size constraints and lack of tissue specificity, Quantix Bio aims to enhance the safety and efficacy of viral and non-viral gene delivery systems. Their technology is designed to be compatible with various therapeutic modalities, including AAV-mediated gene therapy and mRNA-based therapeutics, targeting a wide range of indications in oncology and genetic medicine.